Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study

Yurdaydin, CihanWedemeyer, HeinerCaruntu, Florin A.Curescu, Manuela G.Yalcin, KendalAkarca, Ulus S.Gurel, Selim2024-04-242024-04-2420120270-9139https://hdl.handle.net/11468/2312563rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 studyPegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 studyConference Object56202A203AWOS:000310955601024Q1